台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    70.5
  • 漲跌
    ▼3.1
  • 漲幅
    -4.21%
  • 成交量
    379
  • 產業
    上櫃 生技醫療類股▼2.18%
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-光和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/2455606570758085May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

光和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2800.000.171.0070.50-0.1570-0.02%
2025/03/27473.80374.1073.6015730.17%
2025/03/26875.1900.0074.7085771.39%
2025/03/2500.00173.4076.00-1594-0.17%
2025/03/24872.2400.0072.2085931.35%
2025/03/21272.7000.0072.4025940.34%
2025/03/19773.270.174.1072.606.95981.16%
2025/03/1800.00375.7075.50-3602-0.50%
2025/03/1700.00278.3077.50-2616-0.32%
2025/03/141378.4300.0077.70136172.11%
2025/03/13877.901079.4381.00-2603-0.33%
2025/03/121279.351180.4477.5015850.17%
2025/03/114.178.43277.6581.502.15570.37%
2025/03/10173.608.476.2376.80-7.4518-1.42%
2025/03/07670.93272.6069.9044960.81%
2025/03/0500.00169.0068.90-1484-0.21%
2025/03/04268.55269.7569.6004830.00%
2025/03/03264.40468.8069.60-2483-0.41%
2025/02/27166.0000.0066.2014780.21%
2025/02/26266.3000.0066.4024900.41%
2025/02/250.168.6000.0067.700.15030.02%
2025/02/24167.0000.0068.0015040.20%
2025/02/214.168.9900.0067.804.15080.81%
2025/02/20267.9000.0071.0024970.40%
2025/02/19365.6000.0065.5034900.61%
2025/02/18262.6000.0062.6025020.40%
2025/02/17162.7000.0062.2015210.19%
2025/02/11164.9000.0064.0015940.17%
2025/02/07460.8000.0060.8045890.68%
2025/02/061460.7600.0060.60146002.33%
2025/02/05660.9300.0060.7066050.99%
2025/01/16161.2000.0061.4016130.16%
2025/01/1500.00161.4061.00-1616-0.16%
2025/01/13166.50663.2862.80-5627-0.80%
2025/01/0200.00164.2064.20-1643-0.16%
2024/12/310.265.6000.0064.300.26690.03%
2024/12/270.562.6000.0063.300.56970.07%
2024/12/260.167.9000.0066.600.16920.01%
2024/12/250.174.6400.0074.000.16830.01%
2024/12/2300.00166.2066.40-1680-0.15%
2024/12/19262.20264.2562.7006950.00%
2024/12/1600.00155.0054.50-1679-0.15%
2024/12/120.155.0000.0054.900.16780.01%
2024/12/114.155.2000.0054.904.16660.62%
2024/12/10161.3000.0060.9016480.15%
2024/12/0500.00166.6065.50-1655-0.15%
2024/12/0300.001467.2967.80-14662-2.11%
2024/12/02166.8000.0066.6016630.15%
2024/11/271.169.3700.0066.501.16770.15%
2024/11/260.169.1000.0068.600.16810.01%
2024/11/2500.00171.3071.90-1681-0.15%
2024/11/22273.00274.0073.0006720.00%
2024/11/1400.00667.5569.00-6670-0.89%
2024/11/138.164.12164.0064.007.16521.08%
2024/11/12464.38565.8070.00-1632-0.16%
2024/11/11270.106170.1070.10-59606-9.73%
2024/11/081.180.0500.0077.801.16030.18%
2024/11/07286.8500.0086.1026200.32%
2024/11/060.186.1000.0085.200.16340.02%
2024/11/05184.0000.0084.9016360.16%
2024/11/040.190.0000.0091.800.16370.02%
2024/10/300.195.0300.0093.800.16700.01%
2024/10/290.197.0000.0096.400.16790.01%
2024/10/240.1103.0000.00102.500.16970.01%
2024/10/231104.0000.00104.0017100.14%
2024/10/210105.5000.00105.5007360.01%
2024/10/162118.0000.00117.0027990.25%
2024/10/152.1120.4400.00117.002.18110.25%
2024/10/140121.5000.00121.0008170.00%
2024/10/088.1126.011123.50126.007.18390.84%
2024/10/074.5115.3800.00116.504.58300.54%
2024/09/261134.0000.00133.0017850.13%
2024/09/255157.2000.00147.5057840.64%
2024/09/241157.501161.00159.0007890.00%
2024/09/237156.2100.00158.0077940.88%
2024/09/191172.5000.00177.0017850.13%
2024/09/1800.000.1187.80175.00-0.1779-0.02%
2024/09/1600.005175.20175.50-5780-0.64%
2024/09/121188.5000.00187.5017840.13%
2024/09/065198.2000.00195.0058000.62%
2024/09/055207.004206.50206.0017970.13%
2024/09/032221.501217.00217.0017970.13%
2024/08/301219.0000.00216.0017920.13%
2024/08/293.1219.0200.00221.003.17950.38%
2024/08/284.3213.932212.00210.002.37880.29%
2024/08/272.3220.1500.00220.002.37850.29%
2024/08/2611.4229.3400.00226.0011.47901.44%
2024/08/2300.002225.50229.00-2798-0.25%
2024/08/222.2223.7700.00221.502.27980.28%
2024/08/214.4218.320227.00225.004.48020.55%
2024/08/202.1199.9100.00216.002.18060.25%
2024/08/196196.3300.00201.5068200.73%
2024/08/149192.3900.00192.0098411.07%
2024/08/1315191.9300.00189.00158431.78%
2024/08/125200.005202.80198.0008350.00%
2024/08/0910180.109188.22203.5018240.12%
2024/08/080.1188.5010185.00187.00-9.9794-1.25%
2024/08/072177.0000.00180.0027810.26%
2024/08/054181.505180.70180.00-1768-0.13%
2024/08/029177.068182.50177.5017490.13%
2024/08/019173.7800.00175.5097321.23%
2024/07/316159.3300.00161.0067270.83%
2024/07/191185.0000.00182.0016500.15%
2024/07/1800.001195.00196.50-1611-0.16%
2024/07/171190.5000.00191.0015890.17%
2024/07/1500.001164.00164.50-1554-0.18%
2024/07/111150.5000.00149.0015310.19%
2024/07/014135.5000.00137.5044350.92%
2024/06/2800.000129.00130.0004130.00%
2024/05/2300.000.4100.50100.50-0.4286-0.14%
2024/05/1700.000.178.1078.50-0.1229-0.03%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音